Uhlmann C, Nickel AC, Picard D, Rossi A, Li G, Hildebrandt B, Brockerhoff G, Bendt F, Hübenthal U, Hewera M, Steiger HJ, Wieczorek D, Perrakis A, Zhang W, Remke M, Koch K, Tigges J, Croner RS, Fritsche E, Kahlert UD: Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology. Biotechnol J 17(6): e2100693, 2022. doi: 10.1002/biot.202100693
Friday, 25 March 2022
by Jana Freytag
Sofranko A, Wahle T, Kolling J, Heusinkveld HJ, Stahlmecke B, Rosenbruch M, Albrecht C, Schins RPF: Effects of subchronic dietary exposure to the engineered nanomaterials SiO2 and CeO2 in C57BL/6J and 5xFAD Alzheimer model mice. Part Fibre Toxicol 19(1): 23, 2022. doi: 10.1186/s12989-022-00461-2
Friday, 25 March 2022
by Jana Freytag
Elberskirch L, Sofranko A, Liebing J, Riefler N, Binder K, Bonatto Minella C, Razum M, Mädler L, Unfried K, Schins RPF, Kraegeloh A, van Thriel C: How structured meta data acquisition contributes to reproducibility of nanosafety studies: Evaluation by a Round-Robin Test. Nanomaterials 12(7): 1053, 2022. doi: 10.3390/nano12071053
Thursday, 24 March 2022
by Jana Freytag
Doak SH, Clift MJD, Costa A, Delmaar C, Gosens I, Halappanavar S, Kelly S, Pejinenburg WJGM, Rothen-Rutishauser B, Schins RPF, Stone V, Tran L, Vijver MG, Vogel U, Wohlleben W, Cassee FR: The road to achieving the European Commission’s chemicals strategy for nanomaterial sustainability-A PATROLS perspective on new approach methodologies. Small 18(17): e2200231, 2022. doi: 10.1002/smll.202200231
Thursday, 24 March 2022
by Jana Freytag
Brinkmann V, Romeo M, Larigot L, Hemmers A, Tschage L, Kleinjohann J, Schiavi A, Steinwachs S, Esser C, Menzel R, Giani Tagliabue S, Bonati L, Cox F, Ale-Agha N, Jakobs P, Altschmied J, Haendeler J, Coumoul X, Ventura N: Aryl hydrocarbon receptor-dependent and -independent pathways mediate curcumin anti-aging effects. Antioxidants (Basel) 11(4): 613, 2022. doi: 10.3390/antiox11040613
Wednesday, 23 March 2022
by Jana Freytag
Dragano N, Reuter M, Peters A, Engels M, Schmidt B, Greiser KH, Bohn B, Riedel-Heller S, Karch A, Mikolajczyk R, Krause G, Lang O, Panreck L, Rietschel M, Brenner H, Fischer B, Franzke CW, Gastell S, Holleczek B, Jöckel KH, Kaaks R, Keil T, Kluttig A, Kuss O, Legath N, Leitzmann M, Lieb W, Meinke-Franze C, Michels KB, Obi N, Pischon T, Feinkohl I, Rospleszcz S, Schikowski T, Schulze MB, Stang A, Völzke H, Willich SN, Wirkner K, Zeeb H, Ahrens W, Berger K: Increase in mental disorders during the COVID-19 pandemic-The role of occupational and financial strains. Dtsch Arztebl Int 119(11): 179-187, 2022. doi: 10.3238/arztebl.m2022.0133
Friday, 18 March 2022
by Jana Freytag
Crofton KM, Bassan A, Behl M, Chushak YG, Fritsche E, Gearhart JM, Marty MS, Mumtaz M, Pavan M, Ruiz P, Sachana M, Selvam R, Shafer TJ, Stavitskaya L, Szabo DT, Szabo ST, Tice RR, Wilson D, Woolley D, Myatt GJ: Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches. Comput Toxicol 22: 100223, 2022. doi: 10.1016/j.comtox.2022.100223
Thursday, 17 March 2022
by Jana Freytag